EMILY WILLARD: Open Payments
NPI 1588040703 · VIDALIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 10 payments from 3 companies in 2025. Trend: 2023 $71 · 2024 $0 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 3 | $164 |
| GENZYME CORPORATION | 6 | $120 |
| Optinose US, Inc. | 1 | $25 |
Products named: DAXXIFY, DUPIXENT, Xhance.
Industry payments across LA — which companies pay providers there.
